Glow-in-the-Dark dye could help surgeons spot hidden cancer

NCT ID NCT07134192

Recruiting now Disease control Sponsor: University of Aarhus Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This study tests whether a fluorescent dye called indocyanine green (ICG) can help surgeons see and remove all sarcoma tissue during surgery. 90 adults with soft tissue sarcoma in the trunk or limbs will receive the dye before surgery, and the surgeon will use the glow to guide removal. The goal is to reduce the number of patients who need a second operation because cancer cells were left behind.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: indocyanine green (ICG) dye
What this could lead to: If it works, this technique could help surgeons see and remove more cancer during the first operation, lowering the chance of needing a second surgery.
What could go wrong: This is an early-stage study with only 90 people, so results may not apply to everyone. The dye may not clearly show all cancer cells, and some people may have allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sarcoma soft tissue sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SARCOMA SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES

Contacts and locations

Locations

Aarhus University Hospital
RECRUITING

Aarhus N, 8200, Denmark
Rigshospitalet
RECRUITING

Copenhagen, 2100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.